# R-BL-M-04 Versus R-(DA)-EPOCH and Autologous Stem Cells Transplantation in Patients With High-Grade B-cell Lymphoma Double-hit (HGBL DH) and High-Grade B-cell Lymphoma Not Otherwise Specified (HGBL NOS)

> **NCT03479918** · PHASE3 · UNKNOWN · sponsor: **Elena N.Parovichnikova** · enrollment: 80 (estimated)

## Conditions studied

- Lymphoma, High-Grade

## Interventions

- **DRUG:** R-DA-EPOCH-21
- **DRUG:** R-BL-M-04
- **DRUG:** R-DA-EPOCH-21 + auto-SCT
- **DRUG:** R-BL-M-04 + auto-SCT

## Key facts

- **NCT ID:** NCT03479918
- **Lead sponsor:** Elena N.Parovichnikova
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-03-15
- **Primary completion:** 2021-03-15
- **Final completion:** 2024-03-15
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2018-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03479918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03479918, "R-BL-M-04 Versus R-(DA)-EPOCH and Autologous Stem Cells Transplantation in Patients With High-Grade B-cell Lymphoma Double-hit (HGBL DH) and High-Grade B-cell Lymphoma Not Otherwise Specified (HGBL NOS)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03479918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*